FDA approved first treatment for patients with rare inherited blood clotting disorder
On Nov. 9, 2023, the U.S. Food and Drug Administration approved ‘ Takeda PharmaceuticalsVAdzynma, the first recombinant (genetically…
On Nov. 9, 2023, the U.S. Food and Drug Administration approved ‘ Takeda PharmaceuticalsVAdzynma, the first recombinant (genetically…
On Nov. 8, 2023, the U.S. Food and Drug Administration approved Eli Lilly’s Zepbound (tirzepatide) injection for chronic…
On Nov. 7, 2023, Rolls-Royce, working with Boeing and World Energy, announced that it had carried out a…
On Nov. 7, 2023, the World Health Organization (WHO) announced that it had released a new guidance: モWhole…
On Nov. 6, 2023, the U.S. Department of Agricultureメs (USDA) announced that nearly 1 million chickens on a…
On Nov. 6, 2023, researchers at NYU Grossman School of Medicine announced they had engineered the first mice…
On Nov. 6, 2023, the U.S. Centers for Disease Control and Prevention (CDC) announced that it was conducting…
On Nov. 2, 2023, Abbott announced that it had received U.S. Food and Drug Administration (FDA) approval for…
On Nov. 1, 2023, the International Health Regulations (IHR) National Focal Point of Zambia notified WHO of an…
On Oct. 31, 2023, Novartis announced that the US Food and Drug Administration (FDA) had approved Cosentyxᆴ (secukinumab)…
On Oct. 31, 2023, the U.S. Food and Drug Administration (FDA) announced it had approved Amgen’s Wezlana (ustekinumab-auub)…
On Oct. 31, 2023, Novavax announced that the European Commission had granted approval for Nuvaxovid XBB.1.5 dispersion for…
On Oct. 30, 2023, the California Department of Public Health (CDPH) reported the first locally acquired case of…
On Oct. 27, 2023, the California Institute for Regenerative Medicine (CIRM) awarded $42.1 million to fund various translational…
On Oct. 25, 2023, University of British Columbia researchers announced they had identified buried kimberlite, the rocky home…
On Oct. 25, 2023, Bavarian Nordic announced that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory…
On Oct. 24, 2023, the U.S. Food and Drug Administration approved Servier Pharmaceuticals’ Tibsovo (ivosidenib) for the treatment…
On Oct. 23, 2023, the British Antarctic Survey (BAS) reported that Highly Pathogenic Avian Influenza (HPAI) had been…
On Oct. 20, 2023, the U.S. Centers for Disease Control and Prevention (CDC) reported that among children and…
On Oct. 20, 2023, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved PENBRAYA (meningococcal…
On Oct. 18, 2023, Novavax announced that Singapore’s Health Sciences Authority (HSA) had granted full approval for Novavax’s…
On Oct. 18, 2023, an industry-academic initiative was announced that aimed to create the largest ever database of…
On Oct. 18, 2023, Novavax announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the United…
On Oct. 17, 2023, the U.S. Department of Agriculture’s (USDA) announced a new partnership between the National Bio…
On Oct. 16. 2023, the U.S. Dept. of Health and Human Services reported results of an audit that…
On Oct. 15, 2023, a dengue outbreak was declared by the Ministry of Public Health and Prevention in…
On Oct. 14, 2023, Purdue University ensured that the memory of the former graduate and devoted Boilermaker football…
On Oct. 13, 2023, the National Institute of health (NIH) announced that an investigational drug, encaleret, restored calcium…
On Oct. 12, 2023, the National Institute of health (NIH) announced that a group of international scientists had…
On Oct. 12, 2023, the U.S. Centers for Disease Control and Prevention (CDC) announced that two fatal human…